开始
zrrsys

Myovant Sciences bullish

做多
zrrsys 已更新   
NYSE:MYOV   None
Trend Analysis
0
0
trendanalysis
Myovant Sciences helps women with uterine fibroids and endometriosis and men with prostate cancer by developing new medicines.
stop loss at the red line
评论:
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。